Valeant says sales to Philidor require restatement of results

LAVAL, Que. -- Valeant Pharmaceuticals (TSX:VRX) says it will restate its financial results for 2014 and 2015 after a review found about US$58 million of sales to Philidor were recognized at the wrong time.

See Full Article

The Quebec-based company says it should have recognized the revenue when the products were dispensed to patients, rather than when delivered to Philidor -- an associated company that sold some Valeant specialty drugs.

Valeant estimates that its 2014 earnings will be reduced by 10 cents per share, in U.S. currency, and 2015 earnings will be increased by nine cents per share.

The amounts involved with the Philidor restatement are tiny compared with Valeant's total revenue and profit in 2014. It reported US$8.3 billion of revenue and $1.56 per share of earnings for the 12 months ended Dec. 31, 2014.

In pre-market trading, Valeant shares made up some of Monday's losses. Prior to the company's late-night announcement, Valeant's stock dropped US$9.07 or 11 per cent to close at US$75.92 per share amid news reports that a restatement was coming. Early Tuesday, before markets opened, the stock was trading at US$78.91, up $2.99 from the previous close.

Apart from the disruption caused by any financial restatement by a publicly traded company, Valeant is coping with a previous controversy that erupted last fall when questions were raised about its relationship with Philidor Rx Services.

Valeant's shares fell from $148.66 to $118.61 in heavy trading on Oct. 21. The stock has continued to trade below those levels and hit a 52-week intraday low of US$69.33 in New York on Nov. 18.

Valeant said on Oct. 30 that it had severed ties with the Pennsylvania-based online specialty pharmacy company after reviewing its practices. Philidor subsequently announced that it would cease operations.

The restatement announced this week will delay the filing of Valeant's audited financial report for 2015. The company has scheduled a Feb. 29 conference call to discuss its unaudited fourth-quarter results.



Advertisements

Latest Economic News

  • U.S. congressional committee hearing on current and proposed tariff actions LIVE

    Economic CBC News
    Contact CBC Audience Relations, CBC P.O. Box 500 Station A Toronto, ON Canada, M5W 1E6 Toll-free (Canada only): 1-866-306-4636 TTY/Teletype writer: 1-866-220-6045Contact Us Source
  • Employers now face a time crunch on pot policy

    Economic CTV News
    Employers across Canada are grappling with the new reality of recreational marijuana becoming legal following the passage of Bill C-45 in the Senate. The pending change will mean decades-old workplace policies on the drug will need to be adjusted, and new safety concerns considered. Source
  • Canadian pot company spins out U.S. assets into separate company to stay on right side of law

    Economic CBC News
    Canada's second largest cannabis company plans to place its U.S. assets into a new separate company that will focus on investing in the cannabis and real estate sector there. TSX-listed Aurora Cannabis said Wednesday it plans to distribute units of its subsidiary Australis Capital Inc. Source
  • Couple wants compensation after missing cruise due to flight delays

    Economic CTV News
    An Ontario couple is seeking compensation from an airline after they missed three days of a cruise vacation because their flight was delayed twice. Stephen and Karen Tepperman arrived early at Toronto Pearson International Airport for what was supposed to be a dream holiday to celebrate their 40th wedding anniversary. Source
  • Delta orders 20 Bombardier CRJ900 regional jets: list price US$961 million

    Economic CTV News
    MONTREAL -- Bombardier Inc. says Delta Air Lines Inc. will buy 20 CRJ900 regional jets with a list price totalling about US$961 million. The actual price paid by Delta for the 70-seat planes hasn't been announced. Source
  • U.S. Commerce Secretary Wilbur Ross denies any wrongdoing in shorting stock

    Economic CBC News
    Commerce Secretary Wilbur Ross made a trade betting that the stock in a shipping company with Russian-government ties would fall, a transaction coming just days after he learned of a possible negative news story about his investment in the company. Source
  • Markets have farther to fall if Trump won't back down on trade: Don Pittis

    Economic CBC News
    Business leaders have repeatedly warned that U.S. President Donald Trump's global trade war will hurt, not help, most U.S. companies. So why haven't we seen markets swoon? Yesterday, many shares, including automotive companies, were down sharply. Asian stocks fell too as the U.S. Source
  • Asian stocks take breather from trade tension

    Economic CTV News
    SINGAPORE - Asian markets were mixed on Wednesday as traders sidelined tariffs that the U.S. and China have threatened to impose on one another, focusing on positive housing data instead. KEEPING SCORE: Japan's benchmark Nikkei 225 index rose less than 0.1 per cent to 22,287.42 and South Korea's Kospi gained 0.9 per cent to 2,361.39 in early trading. Source
  • Global stocks rise, unfazed by U.S.-China tensions

    Economic CTV News
    SINGAPORE -- Stock markets rose Wednesday as investors rallied around signs that the global economy was on track despite heated exchanges between the world's two largest economies over trade. KEEPING SCORE: Germany's DAX was up 0.1 per cent to 12,692 and France's CAC 40 added 0.2 per cent to 5,400. Source
  • Pensions to be clawed back from overpaid Sears retirees

    Economic CBC News
    Sears Canada pensioners have been dealt another financial setback. The company that took over the defunct retailer's pension plan says former employees have been getting paid too much — and now they have to pay it back. Source